Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
ProgynyPGNY +4.34%94 OCF Margin % is 13.99% as of Mar. 2026, which is 37% above its 10-year median of 10.22. GuruFocus rates PGNY with a GF Score™ of 94/100 and a GF Value™ of $28.40 (Modestly Overvalued). The stock has 6 warning signs investors should review. Among 18 Healthcare Plans companies, Progyny ranks better than 66.67% on this metric.
The historical rank and industry rank for Progyny's OCF Margin % or its related term are showing as below:
PGNY'
s OCF Margin % Range Over the Past 10 Years
Min: -19.5 Med: 10.22 Max: 17.34
Current: 15.96
During the past 9 years, the highest OCF Margin % of Progyny was 17.34%. The lowest was -19.50%. And the median was 10.22%.
PGNY's OCF Margin % is ranked better than 66.67% of 18
companies
in the Healthcare Plans industry
Industry Median: 5.525
vs PGNY: 15.96
Progyny OCF Margin % Related Terms
Progyny OCF Margin % Historical Data
* Premium members only.
The historical data trend for Progyny's OCF Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Healthcare Plans subindustry, Progyny's OCF Margin %, along with its competitors' market caps and OCF Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Progyny OCF Margin % vs Healthcare Plans Industry
For the Healthcare Plans industry and Healthcare sector, Progyny's OCF Margin % distribution charts can be found below:
* The bar in red indicates where Progyny's OCF Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Progyny (PGNY) has a OCF Margin % of 13.99% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Progyny and its competitors. This is 37% above median its historical median of 10.22. According to the industry distribution chart, Progyny ranks #6 out of 18 companies in the Healthcare Plans industry, placing it in the top 33.3%.
Is Progyny's OCF Margin % too high?
Progyny's current OCF Margin % of 13.99% is 37% above median its 10-year median of 10.22. The Healthcare Plans industry median OCF Margin % is 5.53. Progyny's value of 13.99% is 153.2% above this industry median. Based on the distribution chart, Progyny ranks #6 out of 18 companies in the Healthcare Plans industry, which is above the industry midpoint. Overall, Progyny has a GF Score™ of 94/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Progyny's OCF Margin % compare to CLOV and PFHO?
According to the Healthcare Plans industry distribution chart, Progyny ranks #6 out of 18 companies for OCF Margin %. This puts Progyny in the upper half of its industry. The industry median OCF Margin % is 5.53. Progyny's value of 13.99% is 153.2% above this benchmark. While the company's 10-year median is 10.22 vs. the industry median of 5.53, Progyny has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Healthcare Plans company?
The median OCF Margin % among Healthcare Plans companies is 5.53, based on 18 companies in the industry. Companies in the top quartile (top 25%) have a OCF Margin % significantly above this median, while those in the bottom quartile fall well below. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Progyny's current OCF Margin % of 13.99% is 153.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Progyny and its competitors. For the Healthcare Plans industry, the median OCF Margin % is 5.53 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Progyny's current OCF Margin % is 13.99%, which is 37% above median its own 10-year median of 10.22. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Progyny stock overvalued right now?
Based on GuruFocus' analysis, Progyny (PGNY) is currently considered Modestly Overvalued. The stock's GF Value™ is $28.40, compared to a current price of $31.98 — trading 12.6% above its estimated fair value. The current OCF Margin % is 13.99%, which is 37% above median its 10-year median of 10.22 and 153.2% above the Healthcare Plans industry median of 5.53. Progyny's overall GF Score™ is 94/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Progyny (PGNY), the current OCF Margin % is 13.99% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Progyny (PGNY) Overvalued in 2026?
Based on GuruFocus' analysis, Progyny stock appears to be overvalued.
The current stock price of $31.98 is trading 12.6% above its estimated GF Value™ of $28.40.
GuruFocus considers Progyny to be Modestly Overvalued.
Key valuation signals for PGNY:
OCF Margin %: 13.99% (37% above median its 10-year median of 10.22)
GF Value™: $28.40 vs. price of $31.98 (12.6% above fair value)
Industry Position: 153.2% above the Healthcare Plans median (#6 of 18)
No single metric tells the full story. See the PGNY stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Progyny Inc is a benefits management company specializing in fertility, family building, and women's health benefits solutions. Its clients include employers across various industries. The fertility benefits solution consists of treatment services (Smart Cycles), access to the Progyny network of high-quality fertility specialists that perform the Smart Cycle treatments, and active management of the selective network of high-quality provider clinics.
94GF Score
Get the complete analysis for PGNY
OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
PGNY has been successfully added to your 
